Please Wait
Applying Filters...
menu
    • menu
    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    RVU120

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ryvu Therapeutics Unveils Romaciclib Data At (ASH) 2025 Meeting
    Ryvu Therapeutics Unveils Romaciclib Data At (ASH) 2025 Meeting

    11 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-11/ryvu-therapeutics-presents-new-clinical-data-from-river-81-and-potami-61-studies-of-romaciclib-rvu120-at-the-2025-american-society-of-hematology-as

    PHARMIWEB
    11 Dec 2025
    Share Share
    Ryvu Therapeutics Presents Abstracts On Romaciclib
    Ryvu Therapeutics Presents Abstracts On Romaciclib

    05 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-05/ryvu-therapeutics-announces-three-abstracts-on-romaciclib-rvu120-and-one-abstract-on-dapolsertib-men1703-at-the-2025-american-society-of-hematolog

    PHARMIWEB
    05 Nov 2025
    Share Share
    Ryvu Therapeutics Presents Data On RVU120, RVU305 At AACR Symposium
    Ryvu Therapeutics Presents Data On RVU120, RVU305 At AACR Symposium

    23 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ryvu-therapeutics-presents-clinical-and-preclinical-data-on-rvu120-rvu305-and-novel-synthetic-lethality-programs-at-the-2024-eortc-nci-aacr-symposium-302284548.html

    PR NEWSWIRE
    23 Oct 2024
    Share Share
    Ryvu To Present RVU120 Data At EHA 2024 Congress
    Ryvu To Present RVU120 Data At EHA 2024 Congress

    14 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ryvu-therapeutics-to-present-clinical-and-preclinical-data-on-rvu120-at-the-2024-european-hematology-association-congress-302145195.html

    PR NEWSWIRE
    14 May 2024
    Share Share
    Ryvu Therapeutics Presents Preclinical Data at AACR 2024
    Ryvu Therapeutics Presents Preclinical Data at AACR 2024

    10 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ryvu-therapeutics-presents-preclinical-data-on-rvu120-and-synthetic-lethality-programs-at-the-2024-aacr-annual-meeting-302112710.html

    PR NEWSWIRE
    10 Apr 2024
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.